abstract |
PROBLEM TO BE SOLVED: To provide an anti-epidermal growth factor receptor (EGFR) antibody complexed with auristatin, for example, monomethyloristatin F (MMAF). An anti-EGFR that contains an anti-EGFR antibody drug conjugate (ADC), sugar, histidine and a surfactant, has a pH of about 5-7, and the anti-EGFR ADC is complexed with auristatin. A preparation containing an antibody or an antigen-binding portion thereof. [Selection diagram] None |